Clinical impact of serum bilirubin levels on kidney transplant outcomes

Abstract Serum bilirubin, a potent endogenous antioxidant, has been associated with decreased risks of cardiovascular disease, diabetes, and kidney disease. However, the effects of serum bilirubin on kidney transplant outcomes remain undetermined. We analyzed 1628 patients who underwent kidney trans...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Juhan Lee, Eun Jin Kim, Jae Geun Lee, Beom Seok Kim, Kyu Ha Huh, Myoung Soo Kim, Soon Il Kim, Yu Seun Kim, Dong Jin Joo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/70842599fef24e85b7a2150b643b33f2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:70842599fef24e85b7a2150b643b33f2
record_format dspace
spelling oai:doaj.org-article:70842599fef24e85b7a2150b643b33f22021-12-02T16:36:05ZClinical impact of serum bilirubin levels on kidney transplant outcomes10.1038/s41598-021-86330-y2045-2322https://doaj.org/article/70842599fef24e85b7a2150b643b33f22021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86330-yhttps://doaj.org/toc/2045-2322Abstract Serum bilirubin, a potent endogenous antioxidant, has been associated with decreased risks of cardiovascular disease, diabetes, and kidney disease. However, the effects of serum bilirubin on kidney transplant outcomes remain undetermined. We analyzed 1628 patients who underwent kidney transplantations between 2003 and 2017. Patients were grouped into sex-specific quartiles according to mean serum bilirubin levels, 3–12 months post-transplantation. Median bilirubin levels were 0.66 mg/dL in males and 0.60 mg/dL in females. The intra-individual variability of serum bilirubin levels was low (9%). Serum bilirubin levels were inversely associated with graft loss, death-censored graft failure, and all-cause mortality, independent of renal function, donor status, and transplant characteristics. Multivariable analysis revealed that the lowest serum bilirubin quartile was associated with increased risk of graft loss (HR 2.64, 95% CI 1.67–4.18, P < 0.001), death-censored graft failure (HR 2.97, 95% CI 1.63–5.42, P < 0.001), and all-cause mortality (HR 2.07, 95% CI 1.01–4.22, P = 0.046). Patients with lower serum bilirubin were also at greater risk of rejection and exhibited consistently lower glomerular filtration rates than those with higher serum bilirubin. Serum bilirubin levels were significantly associated with transplantation outcomes, suggesting that bilirubin could represent a therapeutic target for improving long-term transplant outcomes.Juhan LeeEun Jin KimJae Geun LeeBeom Seok KimKyu Ha HuhMyoung Soo KimSoon Il KimYu Seun KimDong Jin JooNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Juhan Lee
Eun Jin Kim
Jae Geun Lee
Beom Seok Kim
Kyu Ha Huh
Myoung Soo Kim
Soon Il Kim
Yu Seun Kim
Dong Jin Joo
Clinical impact of serum bilirubin levels on kidney transplant outcomes
description Abstract Serum bilirubin, a potent endogenous antioxidant, has been associated with decreased risks of cardiovascular disease, diabetes, and kidney disease. However, the effects of serum bilirubin on kidney transplant outcomes remain undetermined. We analyzed 1628 patients who underwent kidney transplantations between 2003 and 2017. Patients were grouped into sex-specific quartiles according to mean serum bilirubin levels, 3–12 months post-transplantation. Median bilirubin levels were 0.66 mg/dL in males and 0.60 mg/dL in females. The intra-individual variability of serum bilirubin levels was low (9%). Serum bilirubin levels were inversely associated with graft loss, death-censored graft failure, and all-cause mortality, independent of renal function, donor status, and transplant characteristics. Multivariable analysis revealed that the lowest serum bilirubin quartile was associated with increased risk of graft loss (HR 2.64, 95% CI 1.67–4.18, P < 0.001), death-censored graft failure (HR 2.97, 95% CI 1.63–5.42, P < 0.001), and all-cause mortality (HR 2.07, 95% CI 1.01–4.22, P = 0.046). Patients with lower serum bilirubin were also at greater risk of rejection and exhibited consistently lower glomerular filtration rates than those with higher serum bilirubin. Serum bilirubin levels were significantly associated with transplantation outcomes, suggesting that bilirubin could represent a therapeutic target for improving long-term transplant outcomes.
format article
author Juhan Lee
Eun Jin Kim
Jae Geun Lee
Beom Seok Kim
Kyu Ha Huh
Myoung Soo Kim
Soon Il Kim
Yu Seun Kim
Dong Jin Joo
author_facet Juhan Lee
Eun Jin Kim
Jae Geun Lee
Beom Seok Kim
Kyu Ha Huh
Myoung Soo Kim
Soon Il Kim
Yu Seun Kim
Dong Jin Joo
author_sort Juhan Lee
title Clinical impact of serum bilirubin levels on kidney transplant outcomes
title_short Clinical impact of serum bilirubin levels on kidney transplant outcomes
title_full Clinical impact of serum bilirubin levels on kidney transplant outcomes
title_fullStr Clinical impact of serum bilirubin levels on kidney transplant outcomes
title_full_unstemmed Clinical impact of serum bilirubin levels on kidney transplant outcomes
title_sort clinical impact of serum bilirubin levels on kidney transplant outcomes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/70842599fef24e85b7a2150b643b33f2
work_keys_str_mv AT juhanlee clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT eunjinkim clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT jaegeunlee clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT beomseokkim clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT kyuhahuh clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT myoungsookim clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT soonilkim clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT yuseunkim clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
AT dongjinjoo clinicalimpactofserumbilirubinlevelsonkidneytransplantoutcomes
_version_ 1718383639071293440